Chengdu Kaijie Bio-Pharmaceutical Co. Ltd

Chengdu Kaijie Bio-Pharmaceutical Co. Ltd. (KJBP) is a leading peptide manufacturer in China. It was founded in Chengdu in March, 2003 by a team of experienced peptide chemists with a combined industrial experience over 50 years. KPBC was recently relocated to its own 120,000-ft2 brand new state-of-the-art facility in the suburb of Chengdu City.

KJBP specializes in the industrial manufacturing of generic bulk peptide APIs (over 30 catalogue therapeutic peptides, refer to Appendix A) and developing custom CMC for pharmaceutical and biotech companies. The new state-of-the-art KJBP facility offers the capacity to carry out industrial scale solid phase peptide synthesis (SPPS) up 40 liters in size (refer to Appendix B). KJBP�s SPPS manufacturing practice of pharmaceutical grade peptide is incompliance with EP, BP or CP in lots up to multi-kilograms in single batch. KJBP has drafted an expansion plan for 2007 to substantially increase the output in order to meet increasing demand for both of its generic catalog and custom peptide products.

KJBP�s manufacturing is controlled by a comprehensive and stringent quality system. KJBP is determined to offer its customers the best experience with a contract bulk peptide manufacturer, xxxxx highest quality product and best customer support with reasonable and competitive pricing and expedite turn-around time. In addition, KJBP also offers a wide range of pharmaceutical developing service at every stage of product development.